Sotera Health Co (SHC) concluded trading on Thursday at a closing price of $11.74, with 0.43 million shares of worth about $5.0 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.09% during that period and on July 03, 2025 the price saw a gain of about 0.90%. Currently the company’s common shares owned by public are about 283.86M shares, out of which, 146.62M shares are available for trading.
Stock saw a price change of 3.39% in past 5 days and over the past one month there was a price change of -4.36%. Year-to-date (YTD), SHC shares are showing a performance of 1.42% which decreased to -14.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $9.53 but also hit the highest price of $17.08 during that period. The average intraday trading volume for Sotera Health Co shares is 1.31 million. The stock is currently trading 1.65% above its 20-day simple moving average (SMA20), while that difference is down -2.41% for SMA50 and it goes to -11.17% lower than SMA200.
Sotera Health Co (NASDAQ: SHC) currently have 283.86M outstanding shares and institutions hold larger chunk of about 49.94% of that.
The stock has a current market capitalization of $3.33B and its 3Y-monthly beta is at 1.81. PE ratio of stock for trailing 12 months is 135.62, while it has posted earnings per share of $0.09 in the same period. Its PEG reads 12.82 and has Quick Ratio of 2.16 while making debt-to-equity ratio of 5.67. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SHC, volatility over the week remained 3.68% while standing at 3.09% over the month.
Stock’s fiscal year EPS is expected to rise by 6.82% while it is estimated to increase by 13.88% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on May 05, 2025 offering a Buy rating for the stock and assigned a target price of $17 to it. Coverage by Goldman stated Sotera Health Co (SHC) stock as a Neutral in their note to investors on December 06, 2024, suggesting a price target of $14 for the stock. On May 21, 2024, Piper Sandler Initiated their recommendations, while on April 03, 2024, Citigroup Upgrade their ratings for the stock with a price target of $16. Stock get a Buy rating from Jefferies on March 25, 2024.
